These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 2377285)

  • 21. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence].
    Akachi K; Matsumoto M; Yasue M; Nakamura N; Kamada M; Ohno T
    No Shinkei Geka; 1991 Dec; 19(12):1129-34. PubMed ID: 1766537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
    Swanson SA; Brooks JJ
    Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors.
    Zaprianov Z; Christov K
    Cytometry; 1988 Jul; 9(4):380-6. PubMed ID: 2841078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferative characteristics and ploidy of human brain tumors by DNA flow cytometry.
    Danova M; Riccardi A; Mazzini G; Ucci G; Montecucco CM; Gaetani P; Silvani V; Knerich R; Butti G; Ascari E
    Basic Appl Histochem; 1986; 30(2):175-80. PubMed ID: 3741314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [DAPI-DNA cytofluorometric study of glioma cells--application of DAPI-DNA cytofluorometry to paraffin embedded archival glioma tissue for nuclear DNA content analysis].
    Nagashima R
    No To Shinkei; 1990 Apr; 42(4):352-9. PubMed ID: 1697181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Flow cytometric and karyotypic studies on meningiomas].
    Katsuyama J
    No Shinkei Geka; 1986 Oct; 14(11):1335-44. PubMed ID: 3808194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I; D'Angelo C; Savarese A; Carlini M; Garofalo A; Bottari L; Santoro E; Giannarelli D; Vecchione A; Zupi G
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro.
    Spaar FW; Ahyai A; Spaar U; Gazsó L; Zimmermann A
    Clin Neuropathol; 1986; 5(4):157-75. PubMed ID: 3757347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study.
    Cruz-Sánchez FF; Miquel R; Rossi ML; Figols J; Palacín A; Cardesa A
    Histol Histopathol; 1993 Jan; 8(1):1-8. PubMed ID: 8443419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
    Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
    Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric determination of DNA content in malignant and benign bone tumours.
    Heliö H; Karaharju E; Nordling S
    Cytometry; 1985 Mar; 6(2):165-71. PubMed ID: 3979218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-tube triple staining method for flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation.
    Corver WE; Bonsing BA; Abeln EC; Vlak-Theil PM; Cornelisse CJ; Fleuren GJ
    Cytometry; 1996 Dec; 25(4):358-66. PubMed ID: 8946143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.